Why the FDA Banned Sale of E-cigarettes to Minors

Since electronic cigarettes hit the market in 2004, their sales have soared. The “vaping” culture has caught on in both adults and young people – the latter trend stirring deep concern among regulators and public health officials, and leading the U.S. Food and Drug Administration (FDA) to ban the sale of e-cigarettes to minors in May 2016.

inhaling from an electronic cigarette.Until then, e-cigarettes had fallen outside the regulatory purview of the FDA. By deeming e-cigarettes to be a tobacco product, the FDA extended its regulatory authority to e-cigarettes as well as cigars and hookah and pipe tobacco. Under this regulation, these products cannot be sold to anyone under age 18, either in stores or online. The rule was set to go into effect 90 days after the May 5, 2016 announcement.
“Until now, tobacco products such as e-cigarettes have been regulated by a patchwork of state and local laws,” says Andy Tan, PhD, MPH, MBA, MBBS, a cancer communication researcher at Dana-Farber.

“This is a significant step towards protecting youth from these previously unregulated products at the national level. Certain issues such as banning use of flavors in tobacco and marketing to youth are not specifically addressed in this ruling. These are important additional restrictions that should be implemented to further protect the public’s health.”

From 2013 to 2014, e-cigarette use among middle and high school students tripled – from 4.5 percent to 13.4 percent, according to a federal survey.

Unlike conventional cigarettes, e-cigs don’t contain or burn tobacco. Instead, they are tubes filled with a flavored, nicotine-containing liquid that is electronically vaporized and inhaled by the user. Although they appear to be much safer than tobacco cigarettes, their long-term health effects are unknown.

A large segment of users say they took up e-cigarettes to help them quit or cut down on tobacco- smoking, and some advocates say the devices could be a useful tool in preventing harm from regular cigarettes and aiding smoking cessation. Whether they actually reduce smoking effectively hasn’t been proven in studies to date, and surveys find that many users continue to smoke tobacco cigarettes as well as the electronic version. Some argue that e-cigarettes may serve as a “gateway” to nicotine addiction, introducing new users into the dangerous habit. Research is continuing on the impact the devices have on population health.
Meanwhile, the vaping trend may be hitting a plateau, in part because of growing concern over the safety of e-cigs. Results of a poll published in May found that about 10 percent of respondents were electronic cigarette users – the same proportion as in a year-earlier poll. At the same time, negative attitudes about the devices increased. In 2015, 38 percent of respondents said they believed vaping was not healthier than smoking; this rose to 47 percent in the 2016 survey.

Comments Sort By Newest

One thought on “Why the FDA Banned Sale of E-cigarettes to Minors

  1. As of September 1, 2016 Worcester smoking age goes to 21. Just a heads up out there… as I understand it, it’s pretty going statewide.

  2. As of September 1, 2016 Worcester smoking age goes to 21. Just a heads up out there… as I understand it, it’s pretty going statewide.

Comments are closed.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Dr. Matthew Davids explores combining ibrutinib with FCR (iFCR) for younger patients with previously-untreated chro… https://t.co/wzVpo47tSa
Dana-Farber @danafarber
“We’re changing the way people are cared for, through #precisionmedicine, precision care, and a total team approach… https://t.co/RnZXsH2rW8
Dana-Farber @danafarber
Cell-weighing method could help doctors choose #cancer drugs: https://t.co/YesjtyxIvR via @MIT https://t.co/0F7wsZSuLJ

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.